South Korea could be the first country to approve stem cell therapy

The Korea Food and Drug Administration (KFDA) could be the first in the world to approve stem cell therapy as a medicine in the world.  According to the Yonhap News Agency, the therapy would treat acute myocardial infarction.  The stem cells are harvested from the person's body then treated and injected back into the heart. It has passed the safety and validity tests needed for approval.

This September, The Cell Therapy Commercialization Summit will be join by AON Insurance, Argenta Advisors and others to identify how companies can ensure reimbursement for cell therapy treatments long before they are approved by the US FDA. For more about the Cell Therapy Commercialization Summit, download the brochure.

What could approval of a stem cell therapy in South Korea mean for other pending approvals across the world?

Share this article with your social network, just click below to share now!

Share |